series-c-plus
Stage
3
Investors
About
Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in oncology, women's health, and organ health. The company provides advanced diagnostic tests that detect genetic conditions, monitor cancer recurrence, and assess transplant rejection through blood-based analysis.
Explore natera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.